During the past decade, Department of General Surgery conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of General Surgery" are "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Adenocarcinoma" (1 trials). Many other conditions were trialed in "Department of General Surgery" in a lesser frequency.

Most popular intervention types in "Department of General Surgery" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Oxaliplatin; Capecitabine" (2 trials), "Oxaliplatin; Capecitabine; concurrent radiotherapy" (1 trials) and "Tegafur, Gimeracil and Oteracil Potassium Capsules；Oxaliplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of General Surgery" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department of General Surgery". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of General Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of General Surgery, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".